Using CXCL10 as a representative of CTL-attracting chemokines, involved in attraction of CXCR3+ CTL implicated with good prognosis for cancer patients [7,11,12,15], we tested whether BCG treatment can enhance intra-tumoral production CXCL10. This evidence concerns the gene CXCR3 and cancer.